Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Grainger, D. J.
	Articles by Bottinger, E. P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Grainger, D. J.
	Articles by Bottinger, E. P.

Allain, C. A., Poon, L. S., Chan, C. S. G., Richmond, W. and Fu,P. C (1974). Enzymatic determination of total serum cholesterol. Clin. Chem 20, 470-479.[Abstract]

Bjorkerud, S (1991). Effects of transforming growth factor-beta1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb 11, 892-902.[Abstract/Free Full Text]

Boring, L., Gosling, J., Cleary, M. and Charo,I. F (1998). Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.[Medline]

Breslow, J. L (1996). Mouse models of atherosclerosis. Science 272, 685-688.[Abstract]

Dang, H., Geiser, A. G., Letterio, J. J., Nakabayashi, T., Kong, L. P., Fernandes, G. and Talal,N (1995). SLE-like autoantibodies and Sj\232grens syndrome-like lymphoproliferation in TGF-beta knockout mice. J. Immunol 155, 3205-3212.[Abstract]

Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson,S. and Akhurst, R. J (1995). Defective hematopoiesis and vasculogenesis in transforming growth factor-beta1 knock out mice. Development 121, 1845-1854.[Abstract]

Diebold, R. J., Eis, M. J., Yin, M. Y., Ormsby, I., Boivin, G. P., Darrow, B. J., Saffitz, J. E. and Doetschman,T (1995). Early-onset multifocal inflammation in the transforming growth factor beta1-null mouse is lymphocyte mediated. Proc. Nat. Acad. Sci. USA 92, 12215-12219.[Abstract/Free Full Text]

Fontaine, R. N., Gossett, R. E, Schroeder, F., O'Toole, B. A., Doetschman, T. and Kier, A. B (1996). Liver and intestinal fatty acid binding proteins in control and TGF-beta1 gene targeted deficient mice. Mol. Cell. Biochem 159, 149-153.[Medline]

Gamble, J. R., Khew-Goodall, Y. and Vadas, M. A (1993). Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol 150, 4494-4503.[Abstract]

Grainger, D. J., Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P. and Lawn,R. M (1993). Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260, 1655-1658.[Abstract/Free Full Text]

Grainger, D. J., Kemp, P. R., Witchell, C. M., Weissberg, P. L. and Metcalfe,J. C (1994). Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. Biochem. J 299, 227-235.

Grainger, D. J. and Metcalfe, J. C (1995). A pivotal role for TGF-beta in atherogenesis?. Biol. Rev 70, 571-596.[Medline]

Grainger, D. J., Metcalfe, J. C., Grace, A. A. and Mosedale,D. E (1998). Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J. Cell Sci 111, 2977-2988.[Abstract]

Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P. and Rollins,B. J (1998). Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281.

Kojima, S., Harpel, P. C. and Rifkin, D. B (1991). Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. J. Cell Biol 113, 1439-1445.[Abstract/Free Full Text]

Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M. and Karlsson, S (1993). Transforming growth factor-beta1 null mutation in mice causes excessive inflammatory response and early death. Proc. Nat. Acad. Sci. USA 90, 770-774.[Abstract/Free Full Text]

Kulkarni, A. B., Ward, J. M., Yaswen, L., Mackall, C. L., Bauer, S. R., Huh, C. G., Gress, R. E. and Karlsson,S (1995). Transforming growth factor-beta1 null mice \320 an animal model for inflammatory disorders. Am. J. Pathol 146, 264-275.[Abstract]

Lawn, R. M., Pearle, A. D., Kunz, L. L., Rubin, E. M., Reckless, J., Metcalfe, J. C. and Grainger,D. J (1996). Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice. J. Biol. Chem 271, 31367-31371.[Abstract/Free Full Text]

Lefer, A. M., Ma, X. L., Weyrich, A. S. and Scalia,R (1993). Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc. Nat. Acad. Sci. USA 90, 1018-1022.[Abstract/Free Full Text]

Majack, R. A (1987). Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell Biol 105, 465-471.[Abstract/Free Full Text]

Majesky, M. W., Lindner, V., Twardzik, D. R., Schwartz, S. M. and Reidy, M. A (1991). Production of transforming growth factor-beta1 during repair of arterial injury. J. Clin. Invest 88, 904-910.

Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., Staels, B., Duverger, N., Scherman, D. and Tedgui, A (1999). Protective role of interleukin-10 in atherosclerosis. Circ. Res 85, 17-24.

McCaffrey, T. A., Du, B., Consigli, S., Szabo, P., Bray, P. J., Hartner, L., Weksler, B. B., Sanborn, T. A., Bergman, G. and Bush, H. L. Jr (1997). Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J. Clin. Invest 100, 2182-2188.[Medline]

McDonald, C. C. and Stewart,H. J (1991). Fatal myocardial infarction in the Scottish adjuvant Tamoxifen trial. Brit. Med. J 303, 435-437.

McGorisk, G. M. and Treasure,C. B (1996). Endothelial dysfunction in coronary heart disease. Curr. Opin. Cardiol 11, 341-350.[Medline]

Mosedale, D. E., Metcalfe, J. C. and Grainger, D. J (1996). Optimization of immunofluorescence methods by quantitative image analysis. J. Histochem. Cytochem 44, 1043-1050.[Abstract]

Nabel, E. G., Shum, L., Pompili, V. J., Yang, Z. Y., San, H., Shu, H. B., Liptay, S., Gold, L., Gordon, D., Derynck, R. and Nabel, G. J (1993). Direct transfer of transforming growth factor-beta1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Nat. Acad. Sci. USA 90, 10759-10763.[Abstract/Free Full Text]

Paigen, B., Morrow, A., Brandon, C., Mitchell, D. and Holmes,P (1985). Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65-73.[Medline]

Paigen, B., Morrow, A., Holmes, P. A., Mitchell, D. and Williams,R. A (1987). Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231-240.[Medline]

Paigen, B., Ishida, B. Y., Verstuyft, J., Winters, R. B. and Albee,D (1990). Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10, 316-323.[Abstract/Free Full Text]

Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M. and Breslow,J. L (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353.[Medline]

Ross, R (1993). The pathogenesis of atherosclerosis \320 a perspective for the 1990s. Nature 362, 801-809.[Medline]

Schulick, A. H., Taylor, A. J., Zuo, W., Qiu, C. B., Dong, G., Woodward, R. N., Agah, R., Roberts, A. B., Virmani, R. and Dichek,D. A (1998). Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc. Nat. Acad. Sci. USA 95, 6983-6988.[Abstract/Free Full Text]

Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M. Y., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N. and Doetschman,T (1992). Targeted disruption of the mouse transforming growth factor-beta1 gene results in multifocal inflammatory disease. Nature 359, 693-699.[Medline]

Vadas, M. A., Gamble, J. R., Rye, K. and Barter, P (1997). Regulation of leucocyte-endothelial interactions of special relevance to atherogenesis. Clin. Exp. Pharmacol. Physiol 24, 33-35.

Williams, J. K., Wagner, J. D., Li, Z., Golden, D. L. and Adams, M. R (1997). Tamoxifen inhibits arterial accumulation of LDL degradation products and progression of coronary artery atherosclerosis in monkeys. Arterioscler. Thromb. Vasc. Biol 17, 403-408.[Abstract/Free Full Text]

Wolf, Y. G., Rasmussen, L. M. and Ruoslahti, E (1994). Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J. Clin. Invest 93, 1172-1178.

Yokode, M., Hammer, R. E., Ishibashi, S., Brown, M. S. and Goldstein,J. L (1990). Diet-induced hypercholesterolaemia in mice: Prevention by overexpression of LDL receptors. Science 250, 1273-1275.[Abstract/Free Full Text]

This article has been cited by other articles:

H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam
An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease
Vascular Medicine, November 1, 2007; 12(4): 299 - 309.
[Abstract] [PDF]

C.-L. Chen, I-H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang
Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis
J. Cell Sci., October 15, 2007; 120(20): 3509 - 3521.
[Abstract] [Full Text] [PDF]

P. Gourdy, A. Schambourg, C. Filipe, V. Douin-Echinard, B. Garmy-Susini, B. Calippe, F. Terce, F. Bayard, and J.-F. Arnal
Transforming Growth Factor Activity Is a Key Determinant for the Effect of Estradiol on Fatty Streak Deposit in Hypercholesterolemic Mice
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2214 - 2221.
[Abstract] [Full Text] [PDF]

O. L. Volger, J. O. Fledderus, N. Kisters, R. D. Fontijn, P. D. Moerland, J. Kuiper, T. J. van Berkel, A.-P. J.J. Bijnens, M. J.A.P. Daemen, H. Pannekoek, et al.
Distinctive Expression of Chemokines and Transforming Growth Factor-{beta} Signaling in Human Arterial Endothelium during Atherosclerosis
Am. J. Pathol., July 1, 2007; 171(1): 326 - 337.
[Abstract] [Full Text] [PDF]

J. L. Mehta and H. Attramadal
The TGF{beta} superfamily in cardiovascular biology
Cardiovasc Res, May 1, 2007; 74(2): 181 - 183.
[Full Text] [PDF]

D. J. Grainger
TGF-{beta} and atherosclerosis in man
Cardiovasc Res, May 1, 2007; 74(2): 213 - 222.
[Abstract] [Full Text] [PDF]

P. L. Hermonat, D. Li, B. Yang, and J. L. Mehta
Mechanism of action and delivery possibilities for TGF{beta}1 in the treatment of myocardial ischemia
Cardiovasc Res, May 1, 2007; 74(2): 235 - 243.
[Abstract] [Full Text] [PDF]

A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]

I. N. Bruce
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
Rheumatology, December 1, 2005; 44(12): 1492 - 1502.
[Abstract] [Full Text] [PDF]

D. J. Grainger and P. M. Schofield
Tamoxifen for the Prevention of Myocardial Infarction in Humans: Preclinical and Early Clinical Evidence
Circulation, November 8, 2005; 112(19): 3018 - 3024.
[Full Text] [PDF]

Q. Shi, J. F Vandeberg, C. Jett, K. Rice, M. M Leland, L. Talley, R. S Kushwaha, D. L Rainwater, J. L Vandeberg, and X. L. Wang
Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 751 - 759.
[Abstract] [Full Text] [PDF]

K. Bostrom, A. F. Zebboudj, Y. Yao, T. S. Lin, and A. Torres
Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-{beta}1 Activity in Endothelial Cells
J. Biol. Chem., December 17, 2004; 279(51): 52904 - 52913.
[Abstract] [Full Text] [PDF]

D. J. Grainger
Transforming Growth Factor {beta} and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 399 - 404.
[Abstract] [Full Text]

T. A. Sanders, T. S Dean, D. Grainger, G. J Miller, and H. Wiseman
Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor {beta}1 concentrations and hemostatic risk factors for coronary heart disease in healthy subjects
Am. J. Clinical Nutrition, August 1, 2002; 76(2): 373 - 377.
[Abstract] [Full Text] [PDF]

E. Porreca, C. Di Febbo, G. Baccante, M. Di Nisio, and F. Cuccurullo
Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1752 - 1757.
[Abstract] [Full Text] [PDF]

E. Lutgens, M. Gijbels, M. Smook, P. Heeringa, P. Gotwals, V. E. Koteliansky, and M. J.A.P. Daemen
Transforming Growth Factor-{beta} Mediates Balance Between Inflammation and Fibrosis During Plaque Progression
Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 975 - 982.
[Abstract] [Full Text] [PDF]

C. A. Argmann, C. H. Van Den Diepstraten, C. G. Sawyez, J. Y. Edwards, R. A. Hegele, B. M. Wolfe, and M. W. Huff
Transforming Growth Factor-{beta}1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants
Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2011 - 2018.
[Abstract] [Full Text] [PDF]

E. Lutgens and M. J.A.P. Daemen
Transforming Growth Factor-{beta}: A Local or Systemic Mediator of Plaque Stability?
Circ. Res., November 9, 2001; 89(10): 853 - 855.
[Full Text] [PDF]

A. Tedgui and Z. Mallat
Anti-Inflammatory Mechanisms in the Vascular Wall
Circ. Res., May 11, 2001; 88(9): 877 - 887.
[Abstract] [Full Text] [PDF]

Z. Mallat, A. Gojova, C. Marchiol-Fournigault, B. Esposito, C. Kamate, R. Merval, D. Fradelizi, and A. Tedgui
Inhibition of Transforming Growth Factor-{beta} Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice
Circ. Res., November 9, 2001; 89(10): 930 - 934.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Grainger, D. J.

Articles by Bottinger, E. P.

Search for Related Content

PubMed

PubMed Citation

Articles by Grainger, D. J.

Articles by Bottinger, E. P.

				C.-L. Chen, I-H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis J. Cell Sci., October 15, 2007; 120(20): 3509 - 3521. [Abstract] [Full Text] [PDF]

				P. Gourdy, A. Schambourg, C. Filipe, V. Douin-Echinard, B. Garmy-Susini, B. Calippe, F. Terce, F. Bayard, and J.-F. Arnal Transforming Growth Factor Activity Is a Key Determinant for the Effect of Estradiol on Fatty Streak Deposit in Hypercholesterolemic Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2214 - 2221. [Abstract] [Full Text] [PDF]

				O. L. Volger, J. O. Fledderus, N. Kisters, R. D. Fontijn, P. D. Moerland, J. Kuiper, T. J. van Berkel, A.-P. J.J. Bijnens, M. J.A.P. Daemen, H. Pannekoek, et al. Distinctive Expression of Chemokines and Transforming Growth Factor-{beta} Signaling in Human Arterial Endothelium during Atherosclerosis Am. J. Pathol., July 1, 2007; 171(1): 326 - 337. [Abstract] [Full Text] [PDF]

				J. L. Mehta and H. Attramadal The TGF{beta} superfamily in cardiovascular biology Cardiovasc Res, May 1, 2007; 74(2): 181 - 183. [Full Text] [PDF]

				D. J. Grainger TGF-{beta} and atherosclerosis in man Cardiovasc Res, May 1, 2007; 74(2): 213 - 222. [Abstract] [Full Text] [PDF]

				P. L. Hermonat, D. Li, B. Yang, and J. L. Mehta Mechanism of action and delivery possibilities for TGF{beta}1 in the treatment of myocardial ischemia Cardiovasc Res, May 1, 2007; 74(2): 235 - 243. [Abstract] [Full Text] [PDF]

				A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]

				I. N. Bruce 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology, December 1, 2005; 44(12): 1492 - 1502. [Abstract] [Full Text] [PDF]

				D. J. Grainger and P. M. Schofield Tamoxifen for the Prevention of Myocardial Infarction in Humans: Preclinical and Early Clinical Evidence Circulation, November 8, 2005; 112(19): 3018 - 3024. [Full Text] [PDF]

				Q. Shi, J. F Vandeberg, C. Jett, K. Rice, M. M Leland, L. Talley, R. S Kushwaha, D. L Rainwater, J. L Vandeberg, and X. L. Wang Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet Am. J. Clinical Nutrition, October 1, 2005; 82(4): 751 - 759. [Abstract] [Full Text] [PDF]

				K. Bostrom, A. F. Zebboudj, Y. Yao, T. S. Lin, and A. Torres Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-{beta}1 Activity in Endothelial Cells J. Biol. Chem., December 17, 2004; 279(51): 52904 - 52913. [Abstract] [Full Text] [PDF]

				D. J. Grainger Transforming Growth Factor {beta} and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 399 - 404. [Abstract] [Full Text]

				T. A. Sanders, T. S Dean, D. Grainger, G. J Miller, and H. Wiseman Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor {beta}1 concentrations and hemostatic risk factors for coronary heart disease in healthy subjects Am. J. Clinical Nutrition, August 1, 2002; 76(2): 373 - 377. [Abstract] [Full Text] [PDF]

				E. Porreca, C. Di Febbo, G. Baccante, M. Di Nisio, and F. Cuccurullo Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1752 - 1757. [Abstract] [Full Text] [PDF]

				E. Lutgens, M. Gijbels, M. Smook, P. Heeringa, P. Gotwals, V. E. Koteliansky, and M. J.A.P. Daemen Transforming Growth Factor-{beta} Mediates Balance Between Inflammation and Fibrosis During Plaque Progression Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 975 - 982. [Abstract] [Full Text] [PDF]

				C. A. Argmann, C. H. Van Den Diepstraten, C. G. Sawyez, J. Y. Edwards, R. A. Hegele, B. M. Wolfe, and M. W. Huff Transforming Growth Factor-{beta}1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2011 - 2018. [Abstract] [Full Text] [PDF]

				E. Lutgens and M. J.A.P. Daemen Transforming Growth Factor-{beta}: A Local or Systemic Mediator of Plaque Stability? Circ. Res., November 9, 2001; 89(10): 853 - 855. [Full Text] [PDF]

				A. Tedgui and Z. Mallat Anti-Inflammatory Mechanisms in the Vascular Wall Circ. Res., May 11, 2001; 88(9): 877 - 887. [Abstract] [Full Text] [PDF]

				Z. Mallat, A. Gojova, C. Marchiol-Fournigault, B. Esposito, C. Kamate, R. Merval, D. Fradelizi, and A. Tedgui Inhibition of Transforming Growth Factor-{beta} Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice Circ. Res., November 9, 2001; 89(10): 930 - 934. [Abstract] [Full Text] [PDF]